Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Rosell

Showing results (41-50 of 565) with videos related to

Pageof 57
Sort By:
The Lancet. Oncology|May 11, 2020
Neoadjuvant atezolizumab plus chemotherapy in resectable non-small-cell lung cancerRafael Rosell, Masaoki Ito
Nature Reviews. Clinical Oncology|June 2, 2016
Lung cancer: Using ctDNA to track EGFR and KRAS mutations in advanced-stage diseaseRafael Rosell, Niki Karachaliou
Journal of Thoracic Disease|June 16, 2017
Neutrophils dominate the immune landscape of non-small cell lung cancerCristina Teixidó, Rafael Rosell
The Lancet. Oncology|March 7, 2018
Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancerRafael Rosell, Niki Karachaliou
Cancer Metastasis Reviews|May 5, 2015
Relationship between gene mutation and lung cancer metastasisRafael Rosell, Niki Karachaliou
The Lancet. Oncology|September 29, 2018
Avelumab in non-small-cell lung cancerRafael Rosell, Niki Karachaliou
Expert Review of Molecular Diagnostics|May 11, 2007
Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy responseEnriqueta Felip, Rafael Rosell
Ebiomedicine|March 25, 2019
Co-mutations in EGFR driven non-small cell lung cancerRafael Rosell, Niki Karachaliou
Annals of Translational Medicine|January 20, 2023
Neoantigen personalized vaccine plus anti-PD-1 antibody in cancer patientsMaría González-Cao, Rafael Rosell
Extracellular Vesicles and Circulating Nucleic Acids|December 19, 2024
Defining the landscape of circRNAs in non-small cell lung cancer and their potential as liquid biopsy biomarkers: a complete review including current methodsCarlos Pedraz-Valdunciel, Rafael Rosell
Pageof 57

Showing results (41-50 of 565) with videos related to

Sort By:
Pageof 57
The Lancet. Oncology|May 11, 2020
Neoadjuvant atezolizumab plus chemotherapy in resectable non-small-cell lung cancerRafael Rosell, Masaoki Ito
Nature Reviews. Clinical Oncology|June 2, 2016
Lung cancer: Using ctDNA to track EGFR and KRAS mutations in advanced-stage diseaseRafael Rosell, Niki Karachaliou
Journal of Thoracic Disease|June 16, 2017
Neutrophils dominate the immune landscape of non-small cell lung cancerCristina Teixidó, Rafael Rosell
The Lancet. Oncology|March 7, 2018
Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancerRafael Rosell, Niki Karachaliou
Cancer Metastasis Reviews|May 5, 2015
Relationship between gene mutation and lung cancer metastasisRafael Rosell, Niki Karachaliou
The Lancet. Oncology|September 29, 2018
Avelumab in non-small-cell lung cancerRafael Rosell, Niki Karachaliou
Expert Review of Molecular Diagnostics|May 11, 2007
Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy responseEnriqueta Felip, Rafael Rosell
Ebiomedicine|March 25, 2019
Co-mutations in EGFR driven non-small cell lung cancerRafael Rosell, Niki Karachaliou
Annals of Translational Medicine|January 20, 2023
Neoantigen personalized vaccine plus anti-PD-1 antibody in cancer patientsMaría González-Cao, Rafael Rosell
Extracellular Vesicles and Circulating Nucleic Acids|December 19, 2024
Defining the landscape of circRNAs in non-small cell lung cancer and their potential as liquid biopsy biomarkers: a complete review including current methodsCarlos Pedraz-Valdunciel, Rafael Rosell
Pageof 57